HOB Biotech Group Suzhou Co Ltd:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:HOB Biotech Group Suzhou Co Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10385
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:15
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
HOB Biotech Group Suzhou Co Ltd (HOB Biotech) is a manufacturer of allergy and autoimmune in vitro diagnostics. It owns and operates bioclia, bioline, and biolisa. The company’s bioclia is engaged in cutting-edge nanoparticle and chemiluminescent technology, and chemiluminescent immuno assays (CLIA) for allergy and autoimmune testing. Its bioline technology, autoimmune line immuno assay (LIA) for auto-antibodies screening used as an aid in the diagnosis of autoimmune diseases such as systemic lupus erythematosus (SLE), mixed connective tissue disease (MCTD), vasculitis, and primary biliary cirrhosis (PBC). The company operates in China. HOB Biotech is headquartered in Suzhou, Jiangsu, China.

HOB Biotech Group Suzhou Co Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
HOB Biotech Group Suzhou Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
HOB Biotech Group Suzhou Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
HOB Biotech Group Suzhou Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
HOB Biotech Group Suzhou Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
HOB Biotech Group Suzhou Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
HOB Biotech Group Suzhou Co Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Theradiag Enters into Distribution Agreement with HOB Biotech 10
HOB Biotech Enters into Distribution Agreement with Theradiag 11
Equity Offering 12
TheraDiag Raises USD2.78 Million in Private Placement of Shares 12
HOB Biotech Group Suzhou Co Ltd – Key Competitors 13
HOB Biotech Group Suzhou Co Ltd – Locations And Subsidiaries 14
Head Office 14
Appendix 15
Methodology 15
About GlobalData 15
Contact Us 15
Disclaimer 15

List of Tables
HOB Biotech Group Suzhou Co Ltd, Medical Equipment, Key Facts 2
HOB Biotech Group Suzhou Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
HOB Biotech Group Suzhou Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
HOB Biotech Group Suzhou Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
HOB Biotech Group Suzhou Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
HOB Biotech Group Suzhou Co Ltd, Deals By Market, 2012 to YTD 2018 8
HOB Biotech Group Suzhou Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Theradiag Enters into Distribution Agreement with HOB Biotech 10
HOB Biotech Enters into Distribution Agreement with Theradiag 11
TheraDiag Raises USD2.78 Million in Private Placement of Shares 12
HOB Biotech Group Suzhou Co Ltd, Key Competitors 13

List of Figures
HOB Biotech Group Suzhou Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
HOB Biotech Group Suzhou Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
HOB Biotech Group Suzhou Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
HOB Biotech Group Suzhou Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
HOB Biotech Group Suzhou Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
HOB Biotech Group Suzhou Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
HOB Biotech Group Suzhou Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
HOB Biotech Group Suzhou Co Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[HOB Biotech Group Suzhou Co Ltd:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bank of Taiwan:企業の戦略・SWOT・財務分析
    Bank of Taiwan - Strategy, SWOT and Corporate Finance Report Summary Bank of Taiwan - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • MEC Holding GmbH:企業の戦略的SWOT分析
    MEC Holding GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Dechra Pharmaceuticals Plc (DPH):企業の財務・戦略的SWOT分析
    Summary Dechra Pharmaceuticals Plc (Dechra) is a manufacturer and distributor of veterinary pharmaceutical products. The company's product portfolio includes vetoryl, felimazole, thyforon, malaseb, canaural, isaderm, cardisure, comfortan, soludox, methoxasol, cyclospray and octacillin, among others. …
  • Zynerba Pharmaceuticals Inc (ZYNE):企業の財務・戦略的SWOT分析
    Summary Zynerba Pharmaceuticals Inc (Zynerba Pharmaceuticals), formerly AllTranz Inc, is a developer of next-generation synthetic cannabinoid therapeutics. The company provides pipeline product candidates such as ZYN002 and ZYN001. Its ZYN002 is a synthetic CBD, a non-euphoric cannabinoid, formulate …
  • ION Geophysical Corp (IO):企業の財務・戦略的SWOT分析
    ION Geophysical Corp (IO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Olin Corporation:企業の戦略・SWOT・財務分析
    Olin Corporation - Strategy, SWOT and Corporate Finance Report Summary Olin Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Kuros Biosciences AG (KURN):製薬・医療:M&Aディール及び事業提携情報
    Summary Kuros Biosciences AG (Kuros Biosciences) is a developer of products for tissue repair and regeneration. It develops a family of bone healing products to address indications in trauma and spine called orthobiologics. It is focused on bone repair for trauma, specifically fracture repair, as we …
  • Invuity Inc (IVTY):企業の財務・戦略的SWOT分析
    Summary Invuity Inc (Invuity) is a medical technology company that develops and markets advanced surgical devices for the minimally invasive and minimal access procedures. The company offers illuminated surgical retractors, single-use handheld aspiration and universal drop-in intracavity illuminator …
  • Realm Therapeutics Plc (RLM):製薬・医療:M&Aディール及び事業提携情報
    Summary Realm Therapeutics Plc (Realm Therapeutics), formerly PuriCore Plc is a biopharmaceutical company that develops small molecule therapies for diseases. The company uses its immunomodulatory technology for treating inflammatory diseases in dermatology, ophthalmology, and other diseases. Its pi …
  • Nuverra Environmental Solutions Inc (NES):石油・ガス:M&Aディール及び事業提携情報
    Summary Nuverra Environmental Solutions Inc (Nuverra), formerly Heckmann Corporation, provides environmental solutions to customers focused on the development and ongoing production of oil and natural gas from shale formations. It provides environmental solutions, including delivery, collection, tre …
  • Naspers Limited:企業のM&A・事業提携・投資動向
    Naspers Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Naspers Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Micell Technologies Inc:企業の製品パイプライン分析2018
    Summary Micell Technologies Inc (Micell) is a medical device company that develops drug delivery systems for the treatment of cardiovascular diseases. The company provides product such as MiStent sirolimus eluting absorbable polymer coronary stent system, a drug-eluting stent that is designed to opt …
  • Inform Genomics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Inform Genomics Inc (Inform Genomics) manufactures and markets genomic-based personalized medicine products for cancer and supportive care. The company’s onpart is a medicinal product, which is used for the treatment of decisions in patients, who receive chemotherapy for colorectal, breast, …
  • Saint-Gobain Weber GmbH:企業の戦略・SWOT・財務分析
    Saint-Gobain Weber GmbH - Strategy, SWOT and Corporate Finance Report Summary Saint-Gobain Weber GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Tenaris SA:戦略・SWOT・企業財務分析
    Tenaris SA - Strategy, SWOT and Corporate Finance Report Summary Tenaris SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • The Master Trust Bank of Japan, Ltd.:企業のM&A・事業提携・投資動向
    The Master Trust Bank of Japan, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Master Trust Bank of Japan, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • Mediobanca Banca di Credito Finanziario S.p.A.:企業の戦略・SWOT・財務情報
    Mediobanca Banca di Credito Finanziario S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Mediobanca Banca di Credito Finanziario S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Shinkin Central Bank:企業の戦略・SWOT・財務情報
    Shinkin Central Bank - Strategy, SWOT and Corporate Finance Report Summary Shinkin Central Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • The Gunma Bank Ltd
    The Gunma Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Gunma Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Aker BioMarine AS:企業の戦略・SWOT・財務分析
    Aker BioMarine AS - Strategy, SWOT and Corporate Finance Report Summary Aker BioMarine AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆